M. B. Sánchez

Evaluation of the primitive fraction by functional in vitro assays at the RNA and DNA level represents a novel tool for complementing molecular monitoring in chronic myeloid leukemia

P. Yankilevich, M. Bianchini, J. Mordoh, 2018, Oncotarget.

miRNome profiling of LSC-enriched CD34+CD38−CD26+ fraction in Ph+ CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool

P. Valent, P. Yankilevich, C. Furtado, 2021, Frontiers in Pharmacology.

Elevated plasma levels of IL-6 and MCP-1 selectively identify CML patients who better sustain molecular remission after TKI withdrawal

M. Bianchini, E. Levy, J. Mordoh, 2023, Journal of Hematology & Oncology.

miRNome profiling of clonal stem cells in Ph+ CML

P. Valent, P. Yankilevich, C. Furtado, 2020, bioRxiv.

Programme for Harmonization to the International Scale in Latin America for BCR-ABL1 quantification in CML patients: findings and recommendations

M. Gutiérrez, C. Santamaria, M. E. Altuna, 2020, Clinical chemistry and laboratory medicine.

Phenotypic and functional analysis in HER2+ targeted therapy of human NK cell subpopulation according to the expression of FcεRIγ and NKG2C in breast cancer patients

M. Rizzo, E. Levy, J. Mordoh, 2023, Cancer Immunology, Immunotherapy.